FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Luana Calabrò

Research Profile

Disorders

Chemicals & Drugs

Physiology

Procedures

Anatomy

Tumor Cell Line

Co-author Network

Publications

TOP 3
Riccardo Danielli; Ester Fonsatti; Anna Maria Di Giacomo; Luana Calabrò; Michele Maio
Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond.
Luana Calabrò; Francesca Colizzi; Alessia Covre; Ornella Cutaia; Riccardo Danielli; Anna Maria Di Giacomo; Ester Fonsatti; Luciano Mutti; Pier Giorgio Natali; Luca Sigalotti; Erica Bertocci; Michele Maio
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications.
Luana Calabrò; Riccardo Danielli; Luca Sigalotti; Michele Maio
Clinical studies with anti-CTLA-4 antibodies in non-melanoma indications.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Luana Calabrò (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Riccardo Danielli; Ester Fonsatti; Anna Maria Di Giacomo; Luana Calabrò; Michele Maio
Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond.
Annals of the New York Academy of Sciences 2012;1270():8-12.
2011: Luana Calabrò; Francesca Colizzi; Alessia Covre; Ornella Cutaia; Riccardo Danielli; Anna Maria Di Giacomo; Ester Fonsatti; Luciano Mutti; Pier Giorgio Natali; Luca Sigalotti; Erica Bertocci; Michele Maio
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications.
Journal of cellular physiology 2011;226(10):2595-600.
2010: Luana Calabrò; Riccardo Danielli; Luca Sigalotti; Michele Maio
Clinical studies with anti-CTLA-4 antibodies in non-melanoma indications.
Seminars in oncology 2010;37(5):460-7.
2010: Elisabetta Fratta; Luca Sigalotti; Francesca Colizzi; Alessia Covre; hugues nicolay; Riccardo Danielli; Ester Fonsatti; Maresa Altomonte; Luana Calabrò; Sandra Coral; Michele Maio
Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma.
Journal of cellular physiology 2010;223(2):352-8.
2009: Anna Maria Di Giacomo; Riccardo Danielli; Massimo Guidoboni; Luana Calabrò; Dora Carlucci; Clelia Miracco; Luca Volterrani; Maria Antonietta Mazzei; Maurizio Biagioli; Maresa Altomonte; Michele Maio
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases.
Cancer immunology, immunotherapy : CII 2009;58(8):1297-306.
2007: Luca Sigalotti; Elisabetta Fratta; Sandra Coral; Enzo Cortini; Alessia Covre; hugues nicolay; Lucia Anzalone; Laura Pezzani; Anna Maria Di Giacomo; Ester Fonsatti; Francesca Colizzi; Maresa Altomonte; Luana Calabrò; Michele Maio
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Journal of cellular physiology 2007;212(2):330-44.
2007: Ester Fonsatti; hugues nicolay; Luca Sigalotti; Luana Calabrò; Laura Pezzani; Francesca Colizzi; Maresa Altomonte; Massimo Guidoboni; Francesco M Marincola; Michele Maio
Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3333-8.
2007: Luana Calabrò; Anna Maria Di Giacomo; Maresa Altomonte; Ester Fonsatti; Maria Antonietta Mazzei; Luca Volterrani; Clelia Miracco; Michele Maio
Primary hepatic epithelioid hemangioendothelioma progressively responsive to interferon-alpha: is there room for novel anti-angiogenetic treatments?
Journal of experimental & clinical cancer research : CR 2007;26(1):145-50.
2006: Eugenia Quartarone; Andrea Alonci; Alessandro Allegra; Giacomo Bellomo; Luana Calabrò; A D'Angelo; Vittorio Del Fabro; A Grasso; Maria Cincotta; Caterina Musolino
Differential levels of soluble angiopoietin-2 and Tie-2 in patients with haematological malignancies.
European journal of haematology 2006;77(6):480-5.
2006: Salvatore Campo; Giuseppe M Campo; Angela Avenoso; Angela D'Ascola; Caterina Musolino; Luana Calabrò; Giacomo Bellomo; Eugenia Quartarone; Alberto Calatroni
Lymphocytes from patients with early stage of B-cell chronic lymphocytic leukaemia and long survival synthesize decorin.
Biochimie 2006;88(12):1933-9.
2005: Valter Gattei; Ester Fonsatti; Luca Sigalotti; Massimo Degan; Anna Maria Di Giacomo; Maresa Altomonte; Luana Calabrò; Michele Maio
Epigenetic immunomodulation of hematopoietic malignancies.
Seminars in oncology 2005;32(5):503-10.
2005: Luana Calabrò; Ester Fonsatti; Maresa Altomonte; Laura Pezzani; Francesca Colizzi; Paola Nanni; Valter Gattei; Luca Sigalotti; Michele Maio
Methylation-regulated expression of cancer testis antigens in primary effusion lymphoma: immunotherapeutic implications.
Journal of cellular physiology 2005;202(2):474-7.
2004: Caterina Musolino; Andrea Alonci; Giacomo Bellomo; Barbara Loteta; Eugenia Quartarone; Domenica Gangemi; Elisabetta Massara; Luana Calabrò
Levels of soluble angiogenin in chronic myeloid malignancies: clinical implications.
European journal of haematology 2004;72(6):416-9.
2003: Luana Calabrò; Ester Fonsatti; Giacomo Bellomo; Andrea Alonci; Francesca Colizzi; Luca Sigalotti; Maresa Altomonte; Caterina Musolino; Michele Maio
Differential levels of soluble endoglin (CD105) in myeloid malignancies.
Journal of cellular physiology 2003;194(2):171-5.
2002: Caterina Musolino; Luana Calabrò; Giacomo Bellomo; Maria Cincotta; Valeria Di Giacomo; Caterina Pezzano; Barbara Loteta; Vincenzo Rizzo; Salvatore Guglielmo; Andrea Alonci
[Lipid profile in hematologic neoplasms].
Recenti progressi in medicina 2002;93(5):298-301.
2002: Chiara De Nardo; Ester Fonsatti; Luca Sigalotti; Luana Calabrò; Francesca Colizzi; Enzo Cortini; Sandra Coral; Maresa Altomonte; Michele Maio
Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells.
Journal of cellular physiology 2002;190(2):200-6.
1999: Caterina Musolino; Luana Calabrò; Andrea Alonci; C Quartarone; Giacomo Bellomo; S Neri; Vincenzo Rizzo; Francesco Pernice; Nicola Frisina
[Hypersplenism: current status and perspectives].
Recenti progressi in medicina 1999;90(9):488-94.
1998: Luana Calabrò; Caterina Musolino; Giovanna Spatari; R Vinci; Alberto Calatroni
Increased concentration of circulating acid glycosaminoglycans in chronic lymphocytic leukaemia and essential thrombocythaemia.
Clinica chimica acta; international journal of clinical chemistry 1998;269(2):185-99.